The Impact of Updated Guidelines and Self-Collection on Cervical Cancer Screening

Deriving Clinical Value from Change

Cervical cancer is the fourth most common cancer among women globally, and 95% of cases are due to human papillomavirus (HPV) infection. In this webinar, explore how HPV genotypes in the population have changed since the introduction of HPV vaccines and how you can adapt to a shifting paradigm. Delve into the latest advancements in HPV testing and updates to American Society for Colposcopy and Cervical Pathology (ASCCP) Enduring Guidelines for cervical cancer screening. Discover how HPV extended genotyping can be used to optimize patient risk stratification and enable HPV persistence tracking. There will also be a discussion of the implications of FDA-approved HPV tests with self-collection in a healthcare setting as a less invasive testing option to extend access to cervical cancer screening.

Learning Objectives

This webinar will help you:

• Analyze the changing prevalence of HPV high-risk genotypes due to vaccination
• Clarify recent changes in ASCCP Enduring Guidelines
• Evaluate the importance of extended genotyping for patient risk stratification and management
• Assess the impact of FDA-approved HPV tests with self-collection in a healthcare setting

Watch on Demand       Download Slides (PDF, 2.5 MB)

Fisher Healthcare is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.™ Program. One P.A.C.E.™ credit-hour will be provided for this complimentary basic level program.

Danielle Clement, MEd, MSN, WHNP-BC, AGNP-C, Women’s Health Clinical Manager at BD

Ms. Clement is a double board-certified women’s health and adult gerontology nurse practitioner. She holds bachelor’s and master’s degrees in nursing from Duke University, a certificate in reproductive endocrinology and infertility from the American Society for Reproductive Medicine (ASRM), and a colposcopy certification from the American Society of Colposcopy and Cervical Pathology (ASCCP). She is credentialed as an HIV Specialist with the American Academy of HIV Medicine (AAHIVM).